New Commercialization Opportunities for Proteomics to Be Presented by KineMed, Inc. at the 14th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed Inc. (www.kinemed.com) announced today that David Fineman, KineMed’s President & CEO, will present at the 14th Annual BIO CEO & Investor Conference at 3:00 pm Monday, February 13th at the Waldorf Astoria in New York, NY. Mr. Fineman’s presentation, which will be broadcast as a simultaneous live webcast during the conference, will be available online at http://www.kinemed.com/webcast.

MORE ON THIS TOPIC